CAS 1169558-38-6

XL413

CAS : 1169558-38-6

XL413

Degré de pureté : ≥98%

Masse moléculaire : 289.72g/mol

Ref: 54-BUP02717

XL413

CAS : 1169558-38-6

XL413 is a novel small molecule that inhibits the replication of HIV-1. It has been shown to be effective in inhibiting replication of HIV-1 in both fetal bovine and human cells, with no toxicity for primary cells or prostate cancer cells. XL413 blocks cellular organelle replication by inhibiting lipid kinase, which is required for the production of phospholipids and subsequent liposome formation. XL413 also inhibits autophagy induction, which may contribute to its antiviral activity. This drug has shown efficacy in reducing ischemic brain damage as well as improving survival rates in pediatric patients with leukemia.

Formule : C₁₄H₁₂ClN₃O₂

Degré de pureté : Min. 95%

Masse moléculaire : 289.72 g/mol

Ref: 3D-UWB55838

XL413

CAS : 1169558-38-6

XL-413 is an oral CDC7 kinase inhibitor, potentially blocking DNA replication, mitosis, and cancer cell growth.

Formule : C₁₄H₁₂ClN₃O₂

Degré de pureté : 98.40% - 99.94%

Couleur et forme : Solid

Masse moléculaire : 289.72

Ref: TM-T3352